Escitalopram: all 280 studies that test it
Page 2 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Characteristics of Sleep Patterns in Young Adults With and Without InsomniaCompletedNCT00177216Phase 4Results posted
- Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C PatientsCompletedNCT00166296Phase 2Results posted
- Depression, Epinephrine, and Platelet FunctionCompletedNCT00166114Phase 4Results posted
- Effectiveness of Escitalopram in the Treatment of Body Dysmorphic DisorderCompletedNCT00149799Phase 3Results posted
- Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected PatientsCompletedNCT00136318Phase 3Results posted
- The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive DisorderCompletedNCT00107120Phase 3Results posted
- Drug Therapy for Generalized Anxiety Disorder Among the ElderlyCompletedNCT00105586Phase 4Results posted
- Lexapro and Pramipexole and to Treat Major DepressionCompletedNCT00086307Phase 2Results posted
- The Effect of SSRIs on Threat of Shock Potentiated Neural CircuitryCompletedNCT07074652Not applicable
- Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleActive, not recruitingNCT06937476Not applicable
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVSuspendedNCT06705478Phase 2
- A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate TabletsCompletedNCT06680531Phase 1
- Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive DisorderCompletedNCT05950061Phase 3
- Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive DisorderCompletedNCT05536414Phase 2
- Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid ArthritisCompletedNCT05480878Phase 3
- A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial TreatmentStatus unknownNCT05145270Phase 4
- Effect of Self-administered tDCS in Patients With MDDCompletedNCT04543123Phase 4
- The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain MechanismsActive, not recruitingNCT04336228Phase 4
- Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy VolunteersCompletedNCT04239339Phase 4
- Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation StudyCompletedNCT04162522Phase 3
- The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive DepressionStatus unknownNCT04156425Not applicable
- Effects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive DisorderCompletedNCT04013464Not applicable
- Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy SubjectsCompletedNCT03912974Phase 1
- Antidepressants Trial in Parkinson's DiseaseCompletedNCT03652870Phase 3
- A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionStatus unknownNCT03623711Early Phase 1
- Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive DisorderCompletedNCT03554447Not applicable
- Biomarkers of Antidepressant Response and Suicidal Events in Depressed YouthCompletedNCT03547219Not applicable
- Anxiety and Depression in Epilepsy: A Pilot Treatment StudyWithdrawnNCT03522987Phase 4
- Comparative Efficacy of Duloxetine vs Escitalopram in Patients With FibromyalgiaCompletedNCT03487211Phase 2/3
- A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 FlutemetamolTerminatedNCT03274817Phase 1
- Cognitive Dysfunction in MDD PatientsStatus unknownNCT03187093Phase 4
- Serotonin and Motor PlasticityStatus unknownNCT03162185Phase 4
- A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward SystemStatus unknownNCT03148522Not applicable
- Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety DisordersStatus unknownNCT03122158Phase 4
- Escitalopram for Agitation in Alzheimer's DiseaseActive, not recruitingNCT03108846Phase 3
- Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancerTerminatedNCT03010761Phase 2
- Treatment Outcome in Major Depressive DisorderCompletedNCT02869035Phase 1
- Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With AnxietyCompletedNCT02818751Not applicable
- Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake InhibitorsStatus unknownNCT02753738Phase 4
- The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma PatientsStatus unknownNCT02623231Phase 2/3
- Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk YouthCompletedNCT02553161Not applicable
- Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive EpisodeTerminatedNCT02532660Phase 3
- The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment DepressionCompletedNCT02480400Not applicable
- The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)TerminatedNCT02407821Phase 2
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional DistressCompletedNCT02246244Phase 3
- Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 GeneStatus unknownNCT02237937Phase 4
- SSRI Study for Functional Dyspepsia (SS)CompletedNCT02153567Phase 3
- A Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram in Elderly VolunteersCompletedNCT02122939Phase 1
- Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive DisorderStatus unknownNCT01997580Phase 4
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed ConditionCompletedNCT01996475Phase 1
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting ConditionCompletedNCT01996462Phase 1
- Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic DrugsCompletedNCT01871701Phase 1
- Escitalopram for the Treatment of Depression in Alzheimer's DiseaseCompletedNCT01841125Phase 4
- An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety SymptomsCompletedNCT01814098Phase 4
- A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionCompletedNCT01814085Phase 4
- Serotonergic Modulation of Motor Function in Subacute and Chronic SCIStatus unknownNCT01788969Phase 1
- Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)Status unknownNCT01753882Phase 1
- Bioequivalence Study of Escitalopram Tablets 10 mgCompletedNCT01745601Phase 1
- Serotonergic System and Violent Video GamesCompletedNCT01644071Not applicable
- A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of EscitalopramCompletedNCT01638689Phase 1
- Sequence Towards Remission in DepressionStatus unknownNCT01628783Phase 4
- Modafinil - Escitalopram Study for Cocaine DependenceCompletedNCT01601730Phase 1
- Lexapro®'s Efficacy After Dose Escalation in Remission StudyCompletedNCT01594866Phase 4
- The Effects of Escitalopram on CytokinesStatus unknownNCT01587326Not applicable
- Escitalopram Treatment In Acute StrokeWithdrawnNCT01561092Phase 4
- Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic DisorderCompletedNCT01551225Phase 4
- Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive DisorderCompletedNCT01541475Phase 4
- Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord InjuryCompletedNCT01538693Not applicable
- Escitalopram in the Treatment of Postpartum DepressionCompletedNCT01527474Not applicable
- Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsWithdrawnNCT01522092Phase 3
- Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)Status unknownNCT01483053Phase 4
- Multimodal Assessment of Neurobiological Markers for Psychiatric DisordersCompletedNCT01477203Phase 4
- Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)CompletedNCT01430520Phase 4
- A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy VolunteersCompletedNCT01418274Phase 1
- Predicting Medication Response in Obsessive Compulsive DisorderCompletedNCT01404871Not applicable
- Bioequivalence Study Comparing Two Formulations of EscitalopramCompletedNCT01395433Phase 1
- The Quietude Study: Quetiapine Use for Agitated DepressionTerminatedNCT01363310Phase 3
- Cipralex® for Anxiety Disorders in AdolescentsStatus unknownNCT01293838Phase 1
- The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke PatientsStatus unknownNCT01278498Phase 4
- Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-ResponseCompletedNCT01251471Phase 4
- EScitalopram PIndolol ONset of ActionTerminatedNCT01219686Phase 2/3
- Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive DisorderCompletedNCT01148472Phase 4
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to RisperidoneCompletedNCT01119638Phase 4
- Neural Responses and Dysphoria: Modulation by a Pharmacological ProbeCompletedNCT01101685Phase 4
- TMC435-TiDP16-C112 - Interaction Trial With AntidepressantsCompletedNCT01090700Phase 1
- Biomarkers for Outcomes In Late-life Depression (BOLD)CompletedNCT01082237Phase 4
- Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk GenotypeStatus unknownNCT01078870Phase 4
- A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy VolunteersCompletedNCT01045083Phase 1
- Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress DisorderCompletedNCT01024140Not applicable
- Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress DisorderStatus unknownNCT01008098Phase 2
- The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)Status unknownNCT00989053Not applicable
- The Early Medication Change (EMC) TrialCompletedNCT00974155Phase 4
- Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth WeightCompletedNCT00971815Not applicable
- Effects on Clinical and Functional Outcome of Escitalopram in Adult Stroke PatientsStatus unknownNCT00967408Phase 4
- Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer TreatmentStatus unknownNCT00935675Phase 3
- Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide ScanningStatus unknownNCT00935246Not applicable
- VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and EscitalopramCompletedNCT00933894Phase 1
- A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in DepressionCompletedNCT00866593Phase 2/3
- Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic DepressionStatus unknownNCT00837564Phase 3